Adult diagnoses (age 15 through 124)

Adult diagnoses (age 15 through 124). — See additional coding rules

T49.5X5S Adverse effect of ophthalmological drugs and preparations, sequela
T49.5X6A Underdosing of ophthalmological drugs and preparations, initial encounter
T49.5X6D Underdosing of ophthalmological drugs and preparations, subsequent encounter
T49.5X6S Underdosing of ophthalmological drugs and preparations, sequela
T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
T49.6X5D Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
T49.6X5S Adverse effect of otorhinolaryngological drugs and preparations, sequela
T49.6X6A Underdosing of otorhinolaryngological drugs and preparations, initial encounter
T49.6X6D Underdosing of otorhinolaryngological drugs and preparations, subsequent encounter
T49.6X6S Underdosing of otorhinolaryngological drugs and preparations, sequela
T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
T49.7X5D Adverse effect of dental drugs, topically applied, subsequent encounter
T49.7X5S Adverse effect of dental drugs, topically applied, sequela
T49.7X6A Underdosing of dental drugs, topically applied, initial encounter
T49.7X6D Underdosing of dental drugs, topically applied, subsequent encounter
T49.7X6S Underdosing of dental drugs, topically applied, sequela
T49.8X5A Adverse effect of other topical agents, initial encounter
T49.8X5D Adverse effect of other topical agents, subsequent encounter
T49.8X5S Adverse effect of other topical agents, sequela
T49.8X6A Underdosing of other topical agents, initial encounter
T49.8X6D Underdosing of other topical agents, subsequent encounter
T49.8X6S Underdosing of other topical agents, sequela
T49.95XA Adverse effect of unspecified topical agent, initial encounter
T49.95XD Adverse effect of unspecified topical agent, subsequent encounter
T49.95XS Adverse effect of unspecified topical agent, sequela
T49.96XA Underdosing of unspecified topical agent, initial encounter
T49.96XD Underdosing of unspecified topical agent, subsequent encounter
T49.96XS Underdosing of unspecified topical agent, sequela
T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
T50.0X5D Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
T50.0X6A Underdosing of mineralocorticoids and their antagonists, initial encounter
T50.0X6D Underdosing of mineralocorticoids and their antagonists, subsequent encounter
T50.0X6S Underdosing of mineralocorticoids and their antagonists, sequela
T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
T50.1X5D Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
T50.1X6A Underdosing of loop [high-ceiling] diuretics, initial encounter
T50.1X6D Underdosing of loop [high-ceiling] diuretics, subsequent encounter
T50.1X6S Underdosing of loop [high-ceiling] diuretics, sequela
T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X5D Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.2X6A Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X6D Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T50.2X6S Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
T50.3X5D Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
T50.3X6A Underdosing of electrolytic, caloric and water-balance agents, initial encounter
T50.3X6D Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter
T50.3X6S Underdosing of electrolytic, caloric and water-balance agents, sequela
T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
T50.4X5D Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
T50.4X6A Underdosing of drugs affecting uric acid metabolism, initial encounter
T50.4X6D Underdosing of drugs affecting uric acid metabolism, subsequent encounter
T50.4X6S Underdosing of drugs affecting uric acid metabolism, sequela
T50.5X5A Adverse effect of appetite depressants, initial encounter
T50.5X5D Adverse effect of appetite depressants, subsequent encounter
T50.5X5S Adverse effect of appetite depressants, sequela
T50.5X6A Underdosing of appetite depressants, initial encounter
T50.5X6D Underdosing of appetite depressants, subsequent encounter
T50.5X6S Underdosing of appetite depressants, sequela
T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
T50.6X5D Adverse effect of antidotes and chelating agents, subsequent encounter
T50.6X5S Adverse effect of antidotes and chelating agents, sequela
T50.6X6A Underdosing of antidotes and chelating agents, initial encounter
T50.6X6D Underdosing of antidotes and chelating agents, subsequent encounter
T50.6X6S Underdosing of antidotes and chelating agents, sequela
T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
T50.7X5D Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
T50.7X6A Underdosing of analeptics and opioid receptor antagonists, initial encounter
T50.7X6D Underdosing of analeptics and opioid receptor antagonists, subsequent encounter
T50.7X6S Underdosing of analeptics and opioid receptor antagonists, sequela
T50.8X5A Adverse effect of diagnostic agents, initial encounter
T50.8X5D Adverse effect of diagnostic agents, subsequent encounter
T50.8X5S Adverse effect of diagnostic agents, sequela
T50.8X6A Underdosing of diagnostic agents, initial encounter
T50.8X6D Underdosing of diagnostic agents, subsequent encounter
T50.8X6S Underdosing of diagnostic agents, sequela
T50.915A Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.915D Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
T50.915S Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
T50.916A Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.916D Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
T50.916S Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela
T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A15D Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A16A Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A16D Underdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T50.A16S Underdosing of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A25D Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
T50.A26A Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A26D Underdosing of mixed bacterial vaccines without a pertussis component, subsequent encounter
T50.A26S Underdosing of mixed bacterial vaccines without a pertussis component, sequela